|EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update|
JS Smolen, R Landewé, FC Breedveld, M Buch, G Burmester, ...
Annals of the rheumatic diseases 73 (3), 492-509, 2014
|Treatment of pulmonary arterial hypertension|
M Humbert, O Sitbon, G Simonneau
New England Journal of Medicine 351 (14), 1425-1436, 2004
|Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community|
C Vitali, S Bombardieri, HM Moutsopoulos, G Balestrieri, W Bencivelli, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1993
|EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases|
S Van Assen, N Agmon-Levin, O Elkayam, R Cervera, MF Doran, ...
Annals of the rheumatic diseases 70 (3), 414-422, 2011
|Anti-inflammatory and immunosuppressive drugs and reproduction|
M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ...
Arthritis research & therapy 8 (3), 1-19, 2006
|European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies|
L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ...
Annals of the rheumatic diseases 71 (1), 4-12, 2012
|Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR …|
JL Nam, KL Winthrop, RF van Vollenhoven, K Pavelka, G Valesini, ...
Annals of the rheumatic diseases 69 (6), 976-986, 2010
|Sjöc; gren's Syndrome: Autoimmune Epithelitis|
Clinical immunology and immunopathology 72 (2), 162-165, 1994
|Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical …|
C Alessandri, M Bombardieri, N Papa, M Cinquini, L Magrini, A Tincani, ...
Annals of the rheumatic diseases 63 (10), 1218-1221, 2004
|Inflammation as “common soil” of the multifactorial diseases|
R Scrivo, M Vasile, I Bartosiewicz, G Valesini
Autoimmunity reviews 10 (7), 369-374, 2011
|Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo|
C Ferri, V Pittoni, A Piccoli, O Laurenti, MR Cassone, C Bellini, G Properzi, ...
The Journal of Clinical Endocrinology & Metabolism 80 (3), 829-835, 1995
|Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid‐like structures in Sjögren's syndrome|
F Barone, M Bombardieri, A Manzo, MC Blades, PR Morgan, ...
Arthritis & Rheumatism 52 (6), 1773-1784, 2005
|Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs|
M Østensen, M Lockshin, A Doria, G Valesini, P Meroni, C Gordon, ...
Rheumatology 47 (suppl_3), iii28-iii31, 2008
|Anti–β2‐glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts|
M Sorice, A Longo, A Capozzi, T Garofalo, R Misasi, C Alessandri, F Conti, ...
Arthritis & Rheumatism 56 (8), 2687-2697, 2007
|Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice|
M Blank, D Faden, A Tincani, J Kopolovic, I Goldberg, B Gilburd, F Allegri, ...
Journal of autoimmunity 7 (4), 441-455, 1994
|Citrullination and autoimmunity|
G Valesini, MC Gerardi, C Iannuccelli, VA Pacucci, M Pendolino, ...
Autoimmunity reviews 14 (6), 490-497, 2015
|Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?|
G Balestrieri, A Tincani, L Spatola, F Allegri, E Prati, R Cattaneo, ...
Lupus 4 (2), 122-130, 1995
|Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived …|
C Vitali, G Palombi, C Baldini, M Benucci, S Bombardieri, M Covelli, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
|Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)|
R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ...
Annals of the rheumatic diseases 74 (5), 859-866, 2015
|Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis …|
M Bombardieri, F Barone, F Humby, S Kelly, M McGurk, P Morgan, ...
The Journal of Immunology 179 (7), 4929-4938, 2007